Skip to main content

Table 4 The comparison of studies in postnatal patients with isolate/syndromic CHD

From: Chromosome microarray analysis in the investigation of children with congenital heart disease

Study

Array type

No. tested

Other diagnosis

PCNVs rates

VOUS rates

Thienpont et al. 2007 [9]

1 Mb BAC

60

MCA, ID

16.7%

11.7%

Richards et al. 2008 [11]

385 K oligo arrays

20

MCA, DD/ID

25%

9.8%

20

None

0

Erdogan et al. 2008 [10]

1 Mb BAC or 1 × 244 K Agilent arrays

105

None

4.7%

Unknow

Greenway et al. 2009 [12]

Affymetrix SNP 6.0

114

None

5.3%

Unknow

Breckpot J et al. 2010 [13]

1 Mb array

150

MCA

17.3%

Unknow

Rauch et al. 2010 [14]

100 K Affymetrix

19

MCA

21%

Unknow

Goldmuntz et al. 2011 [16]

100 K Oligo array

58

MCA

20.7%

3.4%

Breckpot et al. 2011 [15]

Affymetrix SNP 6.0

46

None

4.3%

Unknow

Derwinska et al. 2012 [17]

180 K Oligo

150

MCA

14%

Unknow

Syrmou et al. 2013 [19]

1 × 244 K or 4 × 180 K Agilent arrays

55

MCA

25.5%

Unknow

Bachman et al. 2013 [18]

Roche NimbleGen 135 K arrays

46

MCA

10.9%

Unknow

Our study

Affymetrix CytoScan HD arrays

104

MCA, ID/DD

27.9%

2.9%

  1. BAC bacterial artificial chromosome, MCA multiple congenital anomalies, DD/ID development delay/intellectual disabilities, SNP single nucleotide polymorphism